G, K., P, T., S, S., A, P., & G, J. (2025). The intervention of NLRP3 inflammasome inhibitor: Oridonin against azoxymethane and dextran sulfate sodium-induced colitis-associated colorectal cancer in male BALB/c mice. Naunyn-Schmiedeberg's archives of pharmacology, 398(8), 10731. https://doi.org/10.1007/s00210-025-03871-z
Chicago Style (17th ed.) CitationG, Kaur, Tiwari P, Singla S, Panghal A, and Jena G. "The Intervention of NLRP3 Inflammasome Inhibitor: Oridonin Against Azoxymethane and Dextran Sulfate Sodium-induced Colitis-associated Colorectal Cancer in Male BALB/c Mice." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 8 (2025): 10731. https://doi.org/10.1007/s00210-025-03871-z.
MLA (9th ed.) CitationG, Kaur, et al. "The Intervention of NLRP3 Inflammasome Inhibitor: Oridonin Against Azoxymethane and Dextran Sulfate Sodium-induced Colitis-associated Colorectal Cancer in Male BALB/c Mice." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 8, 2025, p. 10731, https://doi.org/10.1007/s00210-025-03871-z.